Breaking News Instant updates and real-time market news.

AGN

Allergan

$230.54

-7.41 (-3.11%)

09:03
10/13/16
10/13
09:03
10/13/16
09:03

Allergan partners with SonarMD

Allergan announced a collaboration with SonarMD, a leader in population health management, on the development of clinical decision support and patient engagement tools which can be used to facilitate physician identification of patients suffering from Irritable Bowel Syndrome with Diarrhea in clinical practice and monitor their treatment outcomes. Moreover, the companies will establish a patient engagement platform which can be used to evaluate symptoms and health outcomes among patients with IBS-D in a real-world clinical setting. Allergan and SonarMD will leverage the Sonar platform for use with IBS-D patients with the goal of optimizing efficient diagnosis and effective use of treatment options to manage IBS-D in clinical practice. This represents the first application of the SonarMD platform for IBS.

  • 06

    Nov

AGN Allergan
$230.54

-7.41 (-3.11%)

09/26/16
LEER
09/26/16
NO CHANGE
LEER
Shire Xiidra launch to 'significantly' expand dry eye category, says Leerink
Leerink analyst Jason Gerberry remains optimistic that Shire's (SHPG) Xiidra launch will "significantly" expand the category for dry eye disease brands, while not meaningfully eroding Allergan's (AGN) Restasis market leading position. While it's still early in the launch of Xiidra and payer access remains a critical variable, the analyst does not anticipate access being a major barrier. Gerberry reiterates an Outperform rating on both Shire and Allergan's shares.
09/22/16
BERN
09/22/16
NO CHANGE
BERN
Allergan acquisitions positive, says Bernstein
After Allergan bought two companies with NASH drugs and the stock fell, Bernstein analyst Aaron Gal says the acquisitions were viewed as expensive. Gal says "it makes almost no difference" if the deals were expensive, as the important issue is whether the products succeed. He believes that the market would never penalize Roche or Celgene for similar deals, and he thinks this indicates that Allergan is "misvalued." He says that Allergan is his "high conviction buy" stock and keeps a $335 price target on the shares.
09/21/16
GABE
09/21/16
NO CHANGE
GABE
Buy
Gabelli questions if Allergan could target Gilead next
Gabelli analyst Kevin Kedra said that "like most" he was surprised at the price paid and the strategic fit of Allergan's (AGN) deal to buy Tobira Therapeutics (TBRA), but wonders if Allergan CEO Brent Saunders is "playing chess while the market is playing checkers" and could be preparing a bid for Gilead (GILD). After Allergan's "very loud statement about its commitment to NASH and liver disease," a deal for Gilead, the leading company in liver disease and "one of the cheapest companies in pharma/biotech," would appear to make more sense, Kedra tells investors, adding that an acquisition of Gilead at a price of $115 per share would be "highly accretive" for Allergan. The analyst keeps a Buy rating on Allergan shares.
09/21/16
CANT
09/21/16
DOWNGRADE
CANT
Hold
Tobira Therapeutics downgraded to Hold from Buy at Cantor
Cantor analyst Elemer Piros downgraded Tobira (TBRA) after the company agreed to be acquired by Allergan (AGN). Target to $42 from $19.

TODAY'S FREE FLY STORIES

HL

Hecla Mining

$6.07

-0.29 (-4.56%)

21:32
02/23/17
02/23
21:32
02/23/17
21:32
Upgrade
Hecla Mining rating change  »

Hecla Mining upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

RIG

Transocean

$14.31

1.03 (7.76%)

21:31
02/23/17
02/23
21:31
02/23/17
21:31
Downgrade
Transocean rating change  »

Transocean downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

CYOU

Changyou.com

$27.47

-0.56 (-2.00%)

21:30
02/23/17
02/23
21:30
02/23/17
21:30
Upgrade
Changyou.com rating change  »

Changyou.com upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOUR

Tuniu

$8.51

-0.2 (-2.30%)

21:30
02/23/17
02/23
21:30
02/23/17
21:30
Upgrade
Tuniu rating change  »

Tuniu upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFUN

Fang Holdings

$3.00

-0.02 (-0.66%)

21:30
02/23/17
02/23
21:30
02/23/17
21:30
Downgrade
Fang Holdings rating change  »

Fang Holdings downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YY

YY

$45.72

-1.16 (-2.47%)

21:29
02/23/17
02/23
21:29
02/23/17
21:29
Downgrade
YY rating change  »

YY downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUN

Sunoco

$27.56

-0.22 (-0.79%)

21:26
02/23/17
02/23
21:26
02/23/17
21:26
Downgrade
Sunoco rating change  »

Sunoco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

QUNR

Qunar

$30.39

-0.22 (-0.72%)

20:25
02/23/17
02/23
20:25
02/23/17
20:25
Conference/Events
Qunar to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

COG

Cabot Oil & Gas

$22.53

-0.07 (-0.31%)

, FL

Foot Locker

$68.58

-2.44 (-3.44%)

20:25
02/23/17
02/23
20:25
02/23/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

COG

Cabot Oil & Gas

$22.53

-0.07 (-0.31%)

FL

Foot Locker

$68.58

-2.44 (-3.44%)

JCP

J.C. Penney

$6.86

-0.19 (-2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 24

    Feb

IIPR

Innovative Industrial Properties

$18.05

0.05 (0.28%)

20:04
02/23/17
02/23
20:04
02/23/17
20:04
Hot Stocks
White House: Likely to see 'greater enforcement' of federal marijuana laws »

During a press briefing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$136.53

-0.58 (-0.42%)

, SMCI

Super Micro Computer

$27.40

0.3 (1.11%)

19:55
02/23/17
02/23
19:55
02/23/17
19:55
Periodicals
Apple cut ties to Super Micro over security concerns, The Information says »

Apple (AAPL) terminated…

AAPL

Apple

$136.53

-0.58 (-0.42%)

SMCI

Super Micro Computer

$27.40

0.3 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 13

    Mar

HLF

Herbalife

$59.40

-1.34 (-2.21%)

19:45
02/23/17
02/23
19:45
02/23/17
19:45
Hot Stocks
Herbalife says board approves new $1.5B repurchase plan »

In its Q4 earnings report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

AHT

Ashford Hospitality

$7.37

-0.13 (-1.73%)

19:17
02/23/17
02/23
19:17
02/23/17
19:17
Earnings
Ashford Trust reports Q4 AFFO 16c, may not compare to consensus (32c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

PG

Procter & Gamble

$91.13

-0.31 (-0.34%)

, EPC

Edgewell Personal Care

$76.27

-5.44 (-6.66%)

19:13
02/23/17
02/23
19:13
02/23/17
19:13
Hot Stocks
Procter & Gamble says cutting Gillette prices by double digits »

Speaking during the…

PG

Procter & Gamble

$91.13

-0.31 (-0.34%)

EPC

Edgewell Personal Care

$76.27

-5.44 (-6.66%)

UL

Unilever; also tag UN

$46.90

-0.03 (-0.06%)

UN

Unilever; also tag UL

$46.58

-0.17 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 19

    Mar

NSU

Nevsun Resources

$2.94

-0.06 (-2.00%)

19:12
02/23/17
02/23
19:12
02/23/17
19:12
Hot Stocks
Nevsun Resources redeploys $120M to fund Timok »

Nevsun announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSU

Nevsun Resources

$2.94

-0.06 (-2.00%)

19:11
02/23/17
02/23
19:11
02/23/17
19:11
Hot Stocks
Nevsun plans to drill over 130,000 meters during 2017 across 3 countries »

The company is planning…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSU

Nevsun Resources

$2.94

-0.06 (-2.00%)

19:10
02/23/17
02/23
19:10
02/23/17
19:10
Hot Stocks
Nevsun sees Bisha processing 2.4M tonnes of primary one in FY17 »

Nevsun expects Bisha to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSU

Nevsun Resources

$2.94

-0.06 (-2.00%)

19:10
02/23/17
02/23
19:10
02/23/17
19:10
Hot Stocks
Nevsun sees investing $45M at Timok Upper Zone Project in FY17 »

The company expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSU

Nevsun Resources

$2.94

-0.06 (-2.00%)

19:08
02/23/17
02/23
19:08
02/23/17
19:08
Earnings
Nevsun reports FY16 EPS 4c, consensus 7c »

Reports FY16 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBF

SoftBank

$76.88

-0.02 (-0.03%)

, S

Sprint

$8.96

-0.33 (-3.55%)

19:01
02/23/17
02/23
19:01
02/23/17
19:01
Hot Stocks
SoftBank, Sprint, TBCASoft partner in blockchain technology for telecoms »

SoftBank (SFTBF), Sprint…

SFTBF

SoftBank

$76.88

-0.02 (-0.03%)

S

Sprint

$8.96

-0.33 (-3.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 06

    Mar

GOOG

Alphabet

$831.33

0.57 (0.07%)

, GOOGL

Alphabet Class A

$851.00

-0.36 (-0.04%)

18:59
02/23/17
02/23
18:59
02/23/17
18:59
Periodicals
Alphabet's Waymo sues Uber for allegedly stealing trade secrets, Bloomberg says »

Alphabet's Waymo…

GOOG

Alphabet

$831.33

0.57 (0.07%)

GOOGL

Alphabet Class A

$851.00

-0.36 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 06

    Mar

  • 19

    Mar

ALB

Albemarle

$92.41

-0.03 (-0.03%)

18:57
02/23/17
02/23
18:57
02/23/17
18:57
Hot Stocks
Albemarle raises quarterly dividend 5% to 32c from 30.5c per share »

The dividend, which has a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 16

    Mar

UTX

United Technologies

$112.09

-0.57 (-0.51%)

18:32
02/23/17
02/23
18:32
02/23/17
18:32
Hot Stocks
Carrier expands air conditioner, heat pump recall »

United Technologies'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

BREW

Craft Brew

$15.60

-0.25 (-1.58%)

, BUD

AB InBev

$108.76

-0.4 (-0.37%)

18:17
02/23/17
02/23
18:17
02/23/17
18:17
Hot Stocks
Craft Brew reschedules Q4 report to allow additional time for audit »

Craft Brew Alliance…

BREW

Craft Brew

$15.60

-0.25 (-1.58%)

BUD

AB InBev

$108.76

-0.4 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

GLPG

Galapagos NV

$69.96

0.3 (0.43%)

18:17
02/23/17
02/23
18:17
02/23/17
18:17
Hot Stocks
Galapagos doses first healthy volunteer with CF combo GLPG2222, GLPG2451 »

Galapagos announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.